SenokotXTRA

Dosage form: tablet
Ingredients: SENNOSIDES 17.2mg
Labeler: Purdue Products LP
NDC Code: 67618-315

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

SenokotXTRA
(standardized senna concentrate)

Drug Facts

Active ingredient (in each tablet) Purpose

Sennosides 17.2 mg

Purpose

Laxative

Uses
  • relieves occasional constipation (irregularity)
  • generally causes bowel movement in 6-12 hours

Warnings

Do not use
  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have
  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel movements that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions
  • take preferably at bedtime or as directed by a doctor
agestarting dosagemaximum dosage
adults and children 12 years of age and over1 tablet
once a day
2 tablets
twice a day
children 6 to under 12 years1/2 tablet
once a day
1 tablet
twice a day
children under 6ask a doctorask a doctor

Other information
  • each tablet contains: calcium 20 mg
  • store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients croscarmellose sodium, dicalcium phosphate, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, mineral oil, stearic acid, talc, tartaric acid

©2011, Purdue Products L.P.

Dist. by: Purdue Products L.P., Stamford, CT 06901-3431


302602-0A

SenokotXTRA

12 Tablets

SENOKOTXTRA 
standardized senna concentrate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67618-315
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (SENNOSIDES) SENNOSIDES17.2 mg
Inactive Ingredients
Ingredient NameStrength
croscarmellose sodium 
anhydrous lactose 
magnesium stearate 
cellulose, microcrystalline 
mineral oil 
stearic acid 
tartaric acid 
hypromelloses 
anhydrous dibasic calcium phosphate 
Product Characteristics
ColorBROWN (Light Brown) Scoreno score
ShapeROUNDSize9mm
FlavorImprint CodeX
Contains    
Packaging
#Item CodePackage Description
1NDC:67618-315-121 BLISTER PACK in 1 CARTON
112 TABLET in 1 BLISTER PACK
2NDC:67618-315-363 BLISTER PACK in 1 CARTON
212 TABLET in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33409/01/1988
Labeler - Purdue Products LP (141916531)
Registrant - Purdue Pharma LP (932323652)
Establishment
NameAddressID/FEIOperations
Contract Pharmacal Corporation968334974MANUFACTURE(67618-315)

Revised: 02/2014
 
Purdue Products LP

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web4)